KRAS and neoplasm: To further explore the association between KRAS and USP39 dependence in various tumor types, the authors also examined data derived from a genome-wide shRNA screen in 216 cancer cell lines from multiple tumor types (Project Achilles) [120], highlighting a significant positive correlation between the antiproliferative effects of silencing both genes.